Intriguingly, the low ACADL expression group had increased serum AFP levels (P = 0.01), larger tumor size (P = 0.036), promoted vascular invasion (P = 0.004), and recurrence (P = 0.002) (Table 1). The gene discussed is ACADL; the disease is neoplasm.